Serotonin syndrome.
Price LH, Charney DS, Heninger GR.
Am J Psychiatry. 1992 Aug;149(8):1116-7. doi: 10.1176/ajp.149.8.1116b.
ACROSTUDY: an overview.
Trainer PJ.
Horm Res. 2007;68 Suppl 5:68-9. doi: 10.1159/000110480. Epub 2007 Dec 10.
NASH in Nondiabetic Endocrine Disorders.
Wang T, Yang W, Karakas S, Sarkar S.
Metab Syndr Relat Disord. 2018 Sep;16(7):315-320. doi: 10.1089/met.2018.0044. Epub 2018 Jun 6.
Prednisolone-psychosis.
Haits G.
Folia Psychiatr Neurol Jpn. 1966;20(3):269-73. doi: 10.1111/j.1440-1819.1966.tb01227.x.
Neuroleptic-induced supersensitivity psychosis.
Chouinard G, Jones BD, Annable L.
Am J Psychiatry. 1978 Nov;135(11):1409-10. doi: 10.1176/ajp.135.11.1409.
Early-life AFB1 exposure: DNA methylation and hormone alterations.
Rotimi OA, De Campos OC, Adelani IB, Olawole TD, Rotimi SO.
Vitam Horm. 2023;122:237-252. doi: 10.1016/bs.vh.2022.11.004. Epub 2023 Jan 28.
Dopamine and schizophrenia.
Crow TJ, Johnstone EC, Longden A, Owen F.
Adv Biochem Psychopharmacol. 1978;19:301-9.
Tolerability of atypical antipsychotics.
Stanniland C, Taylor D.
Drug Saf. 2000 Mar;22(3):195-214. doi: 10.2165/00002018-200022030-00004.
What's new in burns and metabolism.
Sheridan RL, Tompkins RG.
J Am Coll Surg. 2004 Feb;198(2):243-63. doi: 10.1016/j.jamcollsurg.2003.11.007.
Antithyroid medications and psychosis.
Vita R, Mazzi V, Antonelli A, Benvenga S.
Expert Opin Drug Saf. 2013 Nov;12(6):865-72. doi: 10.1517/14740338.2013.823397. Epub 2013 Jul 25.
